Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis

• Status: Completed
• Trial end date: 2007-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of this study is to investigate the efficacy and safety of bromfenac ophthalmic solution for treatment in subjects with a history of allergic conjunctivitis

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bausch & Lomb Incorporated
• Treatments: Bromfenac; Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• History of clinically active allergic conjunctivitis

• Agree to return for all required visits

• Agree to avoid disallowed meds

Exclusion Criteria:

• Known hypersensitivity to bromfenac and salicylates